USFDA completes inspection of Dr Reddys' API Hyderabad Plant 3
Receives 5 observations under Form 483
Dr Reddys Laboratories announced that the audit of its API Hyderabad Plant 3 at Bollaram, Medak District, Telangana by the USFDA has been completed on 09 March 2018. The company has been issued a Form 483 with five observations.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content